Zobrazeno 1 - 10
of 915
pro vyhledávání: '"R, Cowie"'
Autor:
Nicklas Bergh, Krister Lindmark, Johannes Lissdaniels, Gustav Lanne, Oskar Käck, Martin R. Cowie
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 1153-1162 (2024)
Abstract Aims Recent updates of international treatment guidelines for heart failure with reduced ejection fraction (HFrEF) differ regarding the use of angiotensin receptor neprilysin inhibitor (ARNI) as first‐line treatment. The American Heart Ass
Externí odkaz:
https://doaj.org/article/b4b5211b0c8643dfa9e7725a0229bfcc
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3276-3286 (2023)
Abstract Aims When relying on clinical assessment alone, an estimated 22% of acute heart failure (AHF) patients are missed, so clinical guidelines recommend the use of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) for AHF diagnosis. S
Externí odkaz:
https://doaj.org/article/f39a69cf39ad4d93b6dde8e93d44dcaf
Autor:
David de Gonzalo-Calvo, Pablo Martinez-Camblor, Thalia Belmonte, Ferran Barbé, Kevin Duarte, Martin R. Cowie, Christiane E. Angermann, Andrea Korte, Isabelle Riedel, Josephine Labus, Wolfgang Koenig, Faiez Zannad, Thomas Thum, Christian Bär
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Patients with heart failure with reduced ejection fraction (HFrEF) and central sleep apnea (CSA) are at a very high risk of fatal outcomes. Objective To test whether the circulating miRNome provides additional information for risk
Externí odkaz:
https://doaj.org/article/b56c4c5f1c7347ef9ef5daaf74175507
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 3046-3054 (2023)
Abstract Aims Previous cost‐effectiveness analysis suggests that CardioMEMS is cost‐effective compared with usual care for patients with persistent New York Heart Association class III symptoms and at least one heart failure (HF) hospitalization
Externí odkaz:
https://doaj.org/article/271e2cc5fc394ebda933b21f6835a5f9
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Prior to the Covid-19 pandemic, heart failure (HF) disease management programmes were predominantly delivered in-person, with telemedicine being uncommon. Covid-19 resulted in a rapid shift to “remote-by-default” clinic appoin
Externí odkaz:
https://doaj.org/article/87c5a2c2ad56412ca9d998b6a140c9b7
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0300024 (2024)
Today, with the advent of Large-scale generative Language Models (LLMs) it is now possible to simulate free responses to interview questions such as those traditionally analyzed using qualitative research methods. Qualitative methodology encompasses
Externí odkaz:
https://doaj.org/article/607401a44b77487f9500b83e7e806de4
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 824-833 (2023)
Abstract Aims Many risk prediction models have been proposed for heart failure (HF), but few studies have used only information available to general practitioners (GPs) in primary care electronic health records (EHRs). We describe the predictors and
Externí odkaz:
https://doaj.org/article/dc0458b9a4974f2492c34eacfab8e510
Autor:
Luigina Guasti, Polychronis Dilaveris, Mamas A. Mamas, Dimitrios Richter, Ruxandra Christodorescu, Joost Lumens, Mark J. Schuuring, Stefano Carugo, Jonathan Afilalo, Marc Ferrini, Riccardo Asteggiano, Martin R. Cowie
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2808-2822 (2022)
Abstract Digital health technology is receiving increasing attention in cardiology. The rise of accessibility of digital health tools including wearable technologies and smart phone applications used in medical practice has created a new era in healt
Externí odkaz:
https://doaj.org/article/a763f14d13034509b32820253cff16a7
Autor:
Brian P. Halliday, Ruth Owen, John Gregson, Ali Vazir, Rebecca Wassall, Zohya Khalique, Amrit S. Lota, Upasana Tayal, Daniel J. Hammersley, Richard E. Jones, Dudley J. Pennell, Martin R. Cowie, John G.F. Cleland, Sanjay K. Prasad
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 1616-1624 (2022)
Abstract Aims This study aimed to profile the changes in non‐invasive clinical, biochemical, and imaging markers during withdrawal of therapy in patients with recovered dilated cardiomyopathy, providing insights into the pathophysiology of relapse.
Externí odkaz:
https://doaj.org/article/4b4a9c4d835046cf978ac1a1f29a6654
Autor:
Martin R. Cowie, Andrew Flett, Peter Cowburn, Paul Foley, Badrinathan Chandrasekaran, Ian Loke, Chris Critoph, Roy S. Gardner, Kaushik Guha, Tim R. Betts, Gerry Carr‐White, Amir Zaidi, Hoong Sern Lim, Carl Hayward, Ashish Patwala, Dominic Rogers, Stephen Pettit, Carlo Gazzola, John Henderson, Philip B. Adamson
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 48-56 (2022)
Abstract Aims The CardioMEMS HF System Post‐Market Study (COAST) was designed to evaluate the safety, effectiveness, and feasibility of haemodynamic‐guided heart failure (HF) management using a small sensor implanted in the pulmonary artery of Ne
Externí odkaz:
https://doaj.org/article/7e742d01993c4440ba17a6ab9fa85e66